Pharma News

Pfizer Inc and Ionis Pharmaceuticals, Inc announced the discontinuation of the Pfizer-led clinical development program for vupanorsen (PF-07285557), an investigational antisense therapy that was being evaluated for potential indications in cardiovascular (CV) risk reduction and severe hypertriglyceridemia (SHTG).

Zydus announced that the company has started the supplies of its COVID-19 vaccine ZyCoV-D, to the Government of India against their order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar, Ahmedabad. The group is also planning to make the vaccine available in the private market. ZyCoV-D is a three dose vaccine administered intradermally using the painless PharmaJet® needle free system, Tropis®, on day 0, day 28 and day 56.

Budget 2022 disallows pharmaceutical companies to claim tax cut on freebies to doctors under section 37 of the act. It simply means such expenditure can not be claimed as business deduction, and it will be counted as taxable profit of pharmaceutical industries.

A robot has performed laparoscopic surgery on the soft tissue of a pig without the guiding hand of a human a significant step toward fully automated surgery on humans. Designed by a team of Johns Hopkins University researchers, the Smart Tissue Autonomous Robot, or STAR, is described today in Science Robotics.

Mankind Pharma to buy domestic business of Panacea Biotec Pharma. Both companies entered into an agreement to buy the domestic formulations business of Panacea Biotec Pharma, a subsidiary of Sputnik V maker Panacea Biotec for Rs 1,908 crore.

Technology has taken a centre-stage for the Health Sector in the General Budget presented in the Parliament by Smt Nirmala Sitharaman, Union Minister of Finance. Two new digitally underpinned Schemes have been announced which indicate the key role that digital technology is playing in expanding the access of health and medical care across the country.

Garden soil houses a variety of bacteria and their natural byproducts - including one that may help halt tumor growth. Lankacidins are molecules that can be isolated from Strepomyces rochei, a common bacterium in soil. In addition to antimicrobial properties, a type of lankacidins, called lankacidin C, can inhibit tumor activity in various cancer cell lines, including leukemia, melanoma, ovarian and breast cancers.

Valneva SE a specialty vaccine company, today announced the initiation of a Phase 3 trial in adolescents for its single-shot chikungunya vaccine candidate, VLA1553.

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending to extend the approval of Dupixent® (dupilumab) in the European Union (EU) to include add-on maintenance treatment for children aged 6 to 11 years with severe asthma with type 2 inflammation characterized by raised blood eosinophils and/or raised fractional exhaled nitric oxide (FeNO) who are inadequately controlled on two maintenance therapies.